OncoTargets and Therapy
Volume 10, 2017 - Issue
Open access
67
Views
16
CrossRef citations to date
0
Altmetric
Original Research
miR182 activates the Ras–MEK–ERK pathway in human oral cavity squamous cell carcinoma by suppressing RASA1 and SPRED1
Jinhui Wang1 Department of Clinical Laboratory, Harbin First Hospital
, Wei Wang2 Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Harbin Medical University
, Jichen Li2 Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Harbin Medical University
, Liji Wu2 Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Harbin Medical University
, Mei Song1 Department of Clinical Laboratory, Harbin First Hospital
& Qinggang Meng3 Department of Osteological Surgery, Harbin First Hospital, Harbin, People’s Republic of ChinaCorrespondence[email protected]
Pages 667-679
|
Published online: 07 Feb 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.